vs
GRID DYNAMICS HOLDINGS, INC.（GDYN）とPacira BioSciences, Inc.（PCRX）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pacira BioSciences, Inc.の直近四半期売上が大きい（$196.9M vs $106.2M、GRID DYNAMICS HOLDINGS, INC.の約1.9倍）。GRID DYNAMICS HOLDINGS, INC.の前年同期比売上増加率が高い（5.9% vs 5.1%）。Pacira BioSciences, Inc.の直近四半期フリーキャッシュフローが多い（$43.5M vs $6.1M）。過去8四半期でGRID DYNAMICS HOLDINGS, INC.の売上複合成長率が高い（15.3% vs 8.5%）
Escape Dynamics Inc.はコロラド州に本拠を置くテクノロジー企業で、2010年から2015年にかけて事業を展開し、単段軌道投入可能で電磁駆動の再利用可能なスペースプレーンの市場投入を目指し開発を行っていました。
Pacira BioSciences社は非オピオイド系疼痛管理ソリューションの開発・商業化に特化した専門製薬企業で、主に米国の病院や外来手術センターなどの医療機関に術後鎮痛向け製品を提供し、一部海外市場への展開も進めています。
GDYN vs PCRX — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $106.2M | $196.9M |
| 純利益 | $306.0K | — |
| 粗利率 | 34.0% | 79.5% |
| 営業利益率 | 0.5% | 1.2% |
| 純利益率 | 0.3% | — |
| 売上前年比 | 5.9% | 5.1% |
| 純利益前年比 | -93.2% | — |
| EPS（希薄化後） | $0.01 | $0.05 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $106.2M | $196.9M | ||
| Q3 25 | $104.2M | $179.5M | ||
| Q2 25 | $101.1M | $181.1M | ||
| Q1 25 | $100.4M | $168.9M | ||
| Q4 24 | $100.3M | $187.3M | ||
| Q3 24 | $87.4M | $168.6M | ||
| Q2 24 | $83.0M | $178.0M | ||
| Q1 24 | $79.8M | $167.1M |
| Q4 25 | $306.0K | — | ||
| Q3 25 | $1.2M | $5.4M | ||
| Q2 25 | $5.3M | $-4.8M | ||
| Q1 25 | $2.9M | $4.8M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $4.3M | $-143.5M | ||
| Q2 24 | $-817.0K | $18.9M | ||
| Q1 24 | $-3.9M | $9.0M |
| Q4 25 | 34.0% | 79.5% | ||
| Q3 25 | 33.3% | 80.9% | ||
| Q2 25 | 34.1% | 77.4% | ||
| Q1 25 | 36.8% | 79.7% | ||
| Q4 24 | 36.9% | 78.7% | ||
| Q3 24 | 37.4% | 76.9% | ||
| Q2 24 | 35.6% | 75.1% | ||
| Q1 24 | 34.7% | 71.6% |
| Q4 25 | 0.5% | 1.2% | ||
| Q3 25 | -0.2% | 3.5% | ||
| Q2 25 | -0.1% | 4.7% | ||
| Q1 25 | -2.0% | 1.2% | ||
| Q4 24 | 1.3% | 13.2% | ||
| Q3 24 | 2.4% | -82.8% | ||
| Q2 24 | 0.0% | 15.9% | ||
| Q1 24 | -6.9% | 7.9% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 1.1% | 3.0% | ||
| Q2 25 | 5.2% | -2.7% | ||
| Q1 25 | 2.9% | 2.8% | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 4.9% | -85.1% | ||
| Q2 24 | -1.0% | 10.6% | ||
| Q1 24 | -4.9% | 5.4% |
| Q4 25 | $0.01 | $0.05 | ||
| Q3 25 | $0.01 | $0.12 | ||
| Q2 25 | $0.06 | $-0.11 | ||
| Q1 25 | $0.03 | $0.10 | ||
| Q4 24 | $0.06 | $0.38 | ||
| Q3 24 | $0.05 | $-3.11 | ||
| Q2 24 | $-0.01 | $0.39 | ||
| Q1 24 | $-0.05 | $0.19 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $342.1M | $238.4M |
| 総負債低いほど良い | — | $372.2M |
| 株主資本純資産 | $542.1M | $693.1M |
| 総資産 | $612.9M | $1.3B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.54× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $342.1M | $238.4M | ||
| Q3 25 | $338.6M | $246.3M | ||
| Q2 25 | $336.8M | $445.9M | ||
| Q1 25 | $325.5M | $493.6M | ||
| Q4 24 | $334.7M | $484.6M | ||
| Q3 24 | $231.3M | $453.8M | ||
| Q2 24 | $256.0M | $404.2M | ||
| Q1 24 | $249.4M | $325.9M |
| Q4 25 | — | $372.2M | ||
| Q3 25 | — | $376.7M | ||
| Q2 25 | — | $580.5M | ||
| Q1 25 | — | $583.4M | ||
| Q4 24 | — | $585.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $542.1M | $693.1M | ||
| Q3 25 | $537.7M | $727.2M | ||
| Q2 25 | $532.2M | $757.8M | ||
| Q1 25 | $517.4M | $798.5M | ||
| Q4 24 | $517.8M | $778.3M | ||
| Q3 24 | $400.2M | $749.6M | ||
| Q2 24 | $388.4M | $879.3M | ||
| Q1 24 | $382.8M | $892.2M |
| Q4 25 | $612.9M | $1.3B | ||
| Q3 25 | $613.2M | $1.3B | ||
| Q2 25 | $608.9M | $1.5B | ||
| Q1 25 | $590.9M | $1.6B | ||
| Q4 24 | $592.2M | $1.6B | ||
| Q3 24 | $477.3M | $1.5B | ||
| Q2 24 | $443.6M | $1.6B | ||
| Q1 24 | $435.3M | $1.6B |
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.52× | ||
| Q2 25 | — | 0.77× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 0.75× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $43.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $6.1M | $43.5M |
| FCFマージンFCF / 売上 | 5.7% | 22.1% |
| 設備投資強度設備投資 / 売上 | 3.6% | 0.1% |
| キャッシュ転換率営業CF / 純利益 | 32.34× | — |
| 直近12ヶ月FCF直近4四半期 | $25.3M | $136.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $9.9M | $43.7M | ||
| Q3 25 | $7.0M | $60.8M | ||
| Q2 25 | $14.4M | $12.0M | ||
| Q1 25 | $9.4M | $35.5M | ||
| Q4 24 | $7.1M | $33.1M | ||
| Q3 24 | $9.2M | $53.9M | ||
| Q2 24 | $10.7M | $53.2M | ||
| Q1 24 | $3.2M | $49.1M |
| Q4 25 | $6.1M | $43.5M | ||
| Q3 25 | $2.9M | $57.0M | ||
| Q2 25 | $10.2M | $9.3M | ||
| Q1 25 | $6.0M | $26.9M | ||
| Q4 24 | $4.4M | $31.0M | ||
| Q3 24 | $5.9M | $49.8M | ||
| Q2 24 | $8.0M | $51.6M | ||
| Q1 24 | $43.0K | $46.3M |
| Q4 25 | 5.7% | 22.1% | ||
| Q3 25 | 2.8% | 31.7% | ||
| Q2 25 | 10.1% | 5.1% | ||
| Q1 25 | 6.0% | 15.9% | ||
| Q4 24 | 4.4% | 16.6% | ||
| Q3 24 | 6.8% | 29.6% | ||
| Q2 24 | 9.7% | 29.0% | ||
| Q1 24 | 0.1% | 27.7% |
| Q4 25 | 3.6% | 0.1% | ||
| Q3 25 | 3.9% | 2.2% | ||
| Q2 25 | 4.1% | 1.5% | ||
| Q1 25 | 3.3% | 5.1% | ||
| Q4 24 | 2.6% | 1.1% | ||
| Q3 24 | 3.7% | 2.4% | ||
| Q2 24 | 3.2% | 0.9% | ||
| Q1 24 | 4.0% | 1.7% |
| Q4 25 | 32.34× | — | ||
| Q3 25 | 5.92× | 11.20× | ||
| Q2 25 | 2.73× | — | ||
| Q1 25 | 3.21× | 7.37× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | — | 2.82× | ||
| Q1 24 | — | 5.47× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
GDYN
| Other | $30.6M | 29% |
| Technology Media And Telecom | $30.1M | 28% |
| Financial Service | $24.3M | 23% |
| Manufactured Product Other | $10.8M | 10% |
| Related Party | $7.6M | 7% |
| Health Care | $2.8M | 3% |
PCRX
| EXPAREL | $155.8M | 79% |
| ZILRETTA | $33.0M | 17% |
| Iovera | $7.0M | 4% |
